Hepatitis Forums

Hepatitis B Main Forums => Hepatitis B => Topic started by: Hep Editors on January 08, 2020, 09:43:26 am

Title: Antivirals for Hepatitis B Reduce Liver Cancer Ris
Post by: Hep Editors on January 08, 2020, 09:43:26 am
People who used antiviral medications to treat hepatitis B virus (HBV) had a lower risk of developing hepatocellular carcinoma (HCC), the most common type of liver cancer, according to studies presented this week in Boston at The Liver Meeting, the annual meeting of the American Association for the Study of Liver Diseases (AASLD).

Over years or decades, chronic hepatitis B can lead to liver cirrhosis (severe scarring), liver cancer and liver failure. Nucleoside/nucleotide antiviral medications such as Viread (tenofovir disoproxil fumarate, or TDF), Vemlidy (tenofovir alafenamide, or TAF) and Baraclude (entecavir) can suppress HBV replication during treatment, but they seldom lead to a cure. Nevertheless, viral suppression slows the progression of liver disease.